Diabetes Drug Prevents Heart Failure
Trial shows SGLT-2 inhibition can prevent hospitalization for heart failure, reduce likelihood of renal disease progression in patients with or without established heart disease
Source: BWH News - Category: Hospital Management Source Type: news
More News: Cardiology | Diabetes | Endocrinology | Heart | Heart Disease | Heart Failure | Hospital Management